References
- Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
- Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
- Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. Journal of the American College of Cardiology ; 2022. Available from: doi:10.1016/j.jacc.2019.10.009. Accessed August 30, 2023.
- Misganaw A, Mariam DH, Ali A, Araya T. Epidemiology of major non-communicable diseases in Ethiopia: a systematic review. J Health Popul Nutr. 2014;32(1):1.
- Angaw DA, Ali R, Tadele A, Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord. 2021;21(1):1–9. doi:10.1186/s12872-020-01828-z
- Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
- Prabhakaran D, Jeemon P, Sharma M, et al. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1339–e1351. doi:10.1016/S2214-109X(18)30407-8
- Moran AE, Forouzanfar MH, Roth GA, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1483–1492. doi:10.1161/CIRCULATIONAHA.113.004042
- Khan MA, Hashim MJ, Mustafa H, et al. Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020;12(7). doi:10.7759/cureus.9349
- Mensah G. Ischaemic heart disease in Africa. Heart. 2008;94(7):836–843. doi:10.1136/hrt.2007.136523
- Maru M. The changing pattern of cardiovascular diseases in Ethiopia. East Afr Med J. 1993;70(12):772–776.
- Shashu BA, Ayele MA. The pattern of coronary artery diseases as diagnosed by coronary angiography and the outcome of Percutaneous Coronary Intervention (PCI) in Ethiopia. Ethiop J Health Dev. 2014;28(1):1.
- Khan SQ, Ludman PF. Percutaneous coronary intervention. Medicine. 2022;50(7):437–444. doi:10.1016/j.mpmed.2022.04.008
- Canfield J, Totary-Jain H. 40 years of percutaneous coronary intervention: history and future directions. J Pers Med. 2018;8(4):33. doi:10.3390/jpm8040033
- Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701–706. doi:10.1056/NEJM198703193161201
- The management of coronary artery disease in Ethiopia: emphasis on revascularization. Ethiopian Journal of Health Sciences; 2022 Available from: https://www.ajol.info/index.php/ejhs/article/view/207206. Accessed August 30, 2023.
- Doll JA, Hira RS, Kearney KE, et al. Management of percutaneous coronary intervention complications. Circ Cardiovasc Interv. 2020;13(6):e008962. doi:10.1161/CIRCINTERVENTIONS.120.008962
- Bauer T, Boeder N, Nef HM, et al. Fate of patients with coronary perforation complicating percutaneous coronary intervention (from the euro heart survey percutaneous coronary intervention registry). Am J Cardiol. 2015;116(9):1363–1367. doi:10.1016/j.amjcard.2015.07.056
- Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty – PubMed; 2022. Available from: https://pubmed.ncbi.nlm.nih.gov/29808821/. Accessed August 30, 2023.
- Fanaroff AC, Zakroysky P, Dai D, et al. Outcomes of PCI in relation to procedural characteristics and operator volumes in the United States. J Am Coll Cardiol. 2017;69(24):2913–2924. doi:10.1016/j.jacc.2017.04.032
- George S, Butler R, Nolan J, Mamas MA. Percutaneous coronary intervention and bleeding complications. Eur Med J. 2016;4(1):100–109.
- Ischemic stroke after percutaneous coronary intervention: rare, but devastating*. JACC: Cardiovascular Interventions; 2022. Available from: doi:10.1016/j.jcin.2019.05.013. Accessed August 30, 2023.
- Shoukat S, Gowani SA, Jafferani A, Dhakam SH. Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract. 2010;2010:e649164. doi:10.4061/2010/649164
- Stathopoulos I, Jimenez M, Panagopoulos G, Kwak E. The decline in PCI complication rate: 2003–2006 versus 1999–2002. Hellenic J Cardiol. 2009;50(5):379–387.
- Cowley MJ, Dorros G, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol. 1984;53(12):C12–C16. doi:10.1016/0002-9149(84)90738-0
- Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981. N Engl J Med. 1988;318(5):265–270. doi:10.1056/NEJM198802043180501
- Agrawal SK, Ho DSW, Liu MW, et al. Predictors of thrombotic complications after placement of the flexible coil stent. Am J Cardiol. 1994;73(16):1216–1219. doi:10.1016/0002-9149(94)90186-4
- Ellis SG, Roubin GS, King SB, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8207 procedures. J Am Coll Cardiol. 1988;11(2):211–216. doi:10.1016/0735-1097(88)90082-4
- Kimmel SE, Berlin JA, Strom BL, Laskey WK. Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol. 1995;26(4):931–938. doi:10.1016/0735-1097(95)00294-4
- Khalfallah M, Allaithy A, Maria DA. Incidence, predictors and outcomes of contrast induced nephropathy in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Glob Heart. 2021;16(1). doi:10.5334/gh.1071
- Valappil SP, Kunjukrishnapillai S, Iype M, et al. Predictors of contrast induced nephropathy and the applicability of the Mehran risk score in high risk patients undergoing coronary angioplasty—a study from a tertiary care center in South India. Indian Heart J. 2018;70(3):399–404. doi:10.1016/j.ihj.2017.08.018
- Wang J, Zhang C, Liu Z, Bai Y. Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis. J Int Med Res. 2021;49(4):03000605211005972. doi:10.1177/03000605211005972
- Numasawa Y, Kohsaka S, Ueda I, et al. Incidence and predictors of bleeding complications after percutaneous coronary intervention. J Cardiol. 2017;69(1):272–279. doi:10.1016/j.jjcc.2016.05.003
- Qian G, Fu Z, Guo J, Cao F, Chen Y. Prevention of contrast-induced nephropathy by central venous pressure–guided fluid administration in chronic kidney disease and congestive heart failure patients. JACC Cardiovasc Interv. 2016;9(1):89–96. doi:10.1016/j.jcin.2015.09.026
- Bundhun PK, Huang F. Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):1–12. doi:10.1186/s12872-018-0820-6
- Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24(20):1815–1823. doi:10.1016/S0195-668X(03)00485-8
- Kent KC, Moscucci M, Mansour KA, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20(6):905–913. doi:10.1016/0741-5214(94)90227-5